Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Granules India
Manufacturing
FDA issues Granules India 3 observations after inspection
The FDA issued Granules India three observations following a recent pre-approval inspection at the Indian drugmaker’s U.S. facility.
Joseph Keenan
Jan 31, 2022 10:20am
Marksans dramatically expands metformin recall on NDMA scare
Oct 5, 2020 6:18pm
Sun Pharma recalls metformin after carcinogen test
Sep 23, 2020 10:45am
Belgium's Ajinomoto builds new Indian small-molecule facility
Aug 13, 2020 8:00am
FiercePharmaAsia—Gardasil, Lupin, CANbridge and more
May 26, 2017 9:11am
India's Granules is adding manufacturing, jobs to its U.S. site
May 23, 2017 9:33am
